Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304070 · ClinicalTrials.gov registry record · Phase 3
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 78
- Enrollment target
NCT00304070 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 78 participants.
The verdict
NCT00304070, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 78 participants
- Enrollment target
Study Summary
This phase III clinical trial is studying how well cisplatin-based chemotherapy and/or surgery works in treating young patients with stage I, stage II, stage III or stage IV adrenocortical cancer. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving it after surgery may kill any tumor cells that remain after surgery.
Interventions
- DRUG Cisplatin
- DRUG Doxorubicin Hydrochloride
- DRUG Etoposide
- BIOLOGICAL Filgrastim
- PROCEDURE Conventional Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2007-05-03 |
| Est. Completion | 2023-06-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00304070
The ClinicalTrials.gov registry entry for NCT00304070 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Cisplatin is the first listed.
NCT00304070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00304070 about?
NCT00304070 is a clinical study titled "Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor". This phase III clinical trial is studying how well cisplatin-based chemotherapy and/or surgery works in treating young patients with stage I, stage II, stage III or stage IV adrenocortical cancer. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells...
What is the current status of trial NCT00304070?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 78 participants. The study started on 2007-05-03. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT00304070?
The interventions under investigation include: Cisplatin (DRUG), Doxorubicin Hydrochloride (DRUG), Etoposide (DRUG), Filgrastim (BIOLOGICAL), Conventional Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00304070?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.